Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115175) titled 'The mechanism of Zhejiang fritillaria inhibiting immune imbalance of chronic obstructive pulmonary disease through AHR-IL-17 pathway' on Dec. 23, 2025.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Jiaxing First Hospital
Condition:
Chronic obstructive pulmonary disease
Intervention:
COPD patient group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: COPD patient group:30;Healthy control group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=291113
Pub...